息肉样脉络膜血管病变诊疗进展

doi:10.6040/j.issn.1673-3770.0.2017.543

摘要/Abstract

摘要： 息肉状脉络膜血管病变(PCV)的特点是眼底可见橘红色病灶,吲哚菁绿血管造影显示一个或多个高荧光即息肉样病变,伴或不伴有异常的分支血管网和浆液性和(或)出血性的视网膜色素上皮的脱离。PCV因其独特的临床表现及较高的发病率受到越来越多的关注。随着科学及医疗技术的进步,新的检查设备、疗法和药物被眼科界采用,使得对PCV的认识、诊断与治疗迈向了新阶段。对 PCV在诊断和治疗方面的进展进行综述。

关键词: 息肉样脉络膜血管病变, 诊断, 治疗

Abstract: Polypoid choroidal vasculopathy(PCV)is characterized by visible orange lesions on fundoscopy. Indocyan-nine green angiograph depicts one or more hyperfluorescent polypoid lesions, with or without abnormal branching vasculature, and also serous and hemorrhagic retinal pigment epithelial detachment. Because of its unique clinical features and higher incidence, increasing attention is being paid to PCV. With advances in science and medical technology, new screening devices, therapies, and drugs are being adopted, all of which has led to a new phase in the understanding, diagnosis, and treatment of PCV. This article reviews the progress of PCV in terms of its diagnosis and treatment.

Key words: Polypoidal choroidal vasculopathy, Diagnosis, Treatment

中图分类号:

R774

王仙,李颖,赵博军. 息肉样脉络膜血管病变诊疗进展[J]. 山东大学耳鼻喉眼学报, 2018, 32(2): 103-106.

WANG Xian, LI Ying, ZHAO Bojun. Advances in diagnosis and treatment of polypoid choroidal vasculopathy[J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2018, 32(2): 103-106.

参考文献

[1] Yannuzzi LA, Sorenson J, Spaide RF, et al. Idiopathic polypoidal choroidal vasculopathy(IPCV)[J]. Retina, 1990, 10(1):1-8.
[2] Lim S, Cheung CMG, Wong TY. Asian age-related macular degeneration[J]. Asia Pac J Ophthalmol, 2013, 2(1):32-41.
[3] Sho K, Takahashi K, Yamada H, et al. Polypoidal choroidal vasculopathy: incidence, demographic features, and clinical characteristics[J]. Arch Ophthalmol, 2003, 121(10):1392-1396.
[4] Lim TH, Laude A, Tan CS. Polypoidal choroidal vasculopathy:an angiographic discussion[J]. Eye, 2010, 24(3):483-490.
[5] Wong CW, Wong TY. Polypoidal choroidal vasculopathy in Asians[J]. J Clin Med, 2015, 4:782-821.
[6] Wong CW, Yanagi Y, Lee WK, et al. Age-related macular degeneration and polypoidal choroidal vasculopathy in Asians[J]. Prog Retin Eye Res, 2016, 53:107-139.
[7] 颜昕,王翠,赵博军. 息肉状脉络膜血管病变的临床表现分析[J]. 山东大学耳鼻喉眼学报,2017,31(4):98-102. YAN Xin, WANG Cui, ZHAO Bojun. Clinical manifestations of polypoidal choroidal vasculopathy[J]. J Otolaryngol Ophthalmol Shandong Univ, 2017, 31(4):98-102.
[8] Li Y, You QS, Wei WB, et al. Polypoidal choroidal vasculopathy in adult chinese: the Beijing eye study[J]. Ophthalmol, 2014, 121(11):2290-2291.
[9] Koh AH, Chen LJ, et al. Polypoidal choroidal vasculopathy: evidence-based guidelines for clinical diagnosis and treatment[J]. Retina, 2013, 33(4):686-716.
[10] Desmettre T, Devoisselle JM, Mordon S. Fluorescence properties and metabolic features of indocyanine green(ICG)as related to angiography[J]. Surv Ophthalmol, 2000, 45(1):15-27.
[11] Imamura Y, Engelbert M, Iida T, et al. Polypoidal choroidal vasculopathy: a review[J]. Surv Ophthalmol, 2010, 55(6): 501-515.
[12] Coppens G, Spielberg L, Leys A. Polypoidal choroidal vasculopathy,diagnosis and management[J]. Bull Soc Belge Ophtalmol, 2011(317):39-44.
[13] Yuzawa M, Mori R, Kawamura A. The origins of polypoidal choroidal vasculopathy[J]. Br J Ophthalmol, 2005, 89(5): 602-607.
[14] Ojima Y, Hangai M, Sakamoto A, et al. Improved visualization of polypoidal choroidal vasculopathy lesions using spectral-domain optical coherence tomography[J]. Retina, 2009, 29(1):52-59.
[15] Sato T, Kishi S, Watanabe G, et al. Tomographic features of branching vascular networks in polypoidal choroidal vasculopathy[J]. Retina, 2007, 27(5):589-594.
[16] De Salvo G, Vaz Pereira S, Keane PA, et al. Sensitivity and specificity of spectral-domain optical coherence tomography in detecting idiopathic polypoidal choroidal vasculopathy[J]. Am J Ophthalmol, 2014, 158(6):1228-1238.
[17] Chang YS, Kim JH, Kim JW, et al. Optical coherence tomography-based diagnosis of polypoidal choroidal vasculopathy in korean patients[J]. Kor J Ophthalmol, 2016, 30(3):198.
[18] 张怡,姚静,王肖华,等. 光学相干断层扫描诊断息肉状脉络膜血管病变的敏感性和特异性[J]. 南方医科大学学报,2017,37(2):165-171. ZHANG Yi, YAO Jing, WANG Xiaohua, et al. Sensitivity and specificity of optical coherence tomography in diagnosing polypoidal choroidal vasculopathy [J]. J Sout Med Univ, 2017, 37(2):165-171.
[19] Tomiyasu T, Nozaki M, Yoshida M, et al. Characteristics of polypoidal choroidal vasculopathy evaluated by optical coherence tomography angiography[J]. Invest Ophthalmol Vis Sci, 2016, 57(9):324-330.
[20] Kim JY, Kwon OW, Oh HS, et al. Optical coherence tomography angiography in patients with polypoidal choroidal vasculopathy[J]. Graefes Arch Clin Exp Ophthalmo, 2016, 254(8):1505-1510.
[21] Inoue M, Balaratnasingam C, Freund KB. Optical coherence tomography angiography of polypoidal choroidal vasculopathy and polypoidal choroidal neovascularization[J]. Retina, 2015, 35(11):2265-2274.
[22] Wang M, Zhou Y, Gao SS, et al. Evaluating polypoidal choroidal vasculopathy with optical coherence tomography angiography[J]. Invest Ophthalmol Vis Sci, 2016, 57(9):526-532.
[23] Takayama K, Ito Y, Kaneko H, et al. Comparison of indocyanine green angiography and optical coherence tomographic angiography in polypoidal choroidal vasculopathy[J]. Eye, 2017, 31(1):45-52.
[24] Wong IY, Shi X, Gangwani R, et al. One-year results of half- versus standard-dose photodynamic therapy combined with ranibizumab for polypoidal choroidal vasculopathy[J]. Retina, 2017. DOI: 10.1097/IAE.0000000000001614.
[25] Hikichi T. Six-year outcomes of antivascular endothelial growth factor monotherapy for polypoidal choroidal vasculopathy[J]. Br J Ophthalmol, 2018, 102(1):97-101.
[26] 杨景元,王尔茜,陈有信.光动力疗法与玻璃体腔注射抗血管内皮生长因子制剂治疗息肉样脉络膜血管病变的Meta分析[J].中华眼底病杂志,2016,32(1):73-78. YANG Jingyuan, WANG Erqian, CHEN Youxin, et al. Meta-analysis of photodynamic therapy and intravitreal injection of anti-vascular endothelial growth factor agent in the treatment of polypoid choroidal vasculopathy[J]. Chin J Ocul Fund Dis, 2016, 32(1):73-78.
[27] Koh A, Lee WK, Chen LJ, et al. EVEREST study: efficacy and safety of verteporfin photodynamic therapy in combination with ranibizumab or alone versus ranibizumab monotherapy in patients with symptomatic macular polypoidal choroidal vasculopathy[J]. Retina, 2012, 32(8):1453-1464.
[28] Gomi F, Sawa M, Wakabayashi T, et al. Efficacy of intravitreal bevacizumab combined with photodynamic therapy for polypoidal choroidal vasculopathy[J]. Am J Ophthalmol, 2010, 150(1):48-54.
[29] Koh A, Lai TYY, Takahashi K, et al. Efficacy and safety of ranibizumab with or without verteporfin photodynamic therapy for polypoidal choroidal vasculopathy: a randomized clinical trial[J]. JAMA Ophthalmol, 2017, 135(11):1206-1213.

相关文章 15

[1]	吴静,刘业海. 头颈部鳞状细胞癌的靶向治疗研究进展[J]. 山东大学耳鼻喉眼学报, 2018, 32(5): 97-102.
[2]	沈勤峰,沈小燕,朱荣强,蒋斐斐,郎军添. 鼻内镜下中鼻甲功能性部分切除治疗慢性鼻窦炎76例分析[J]. 山东大学耳鼻喉眼学报, 2018, 32(5): 82-85.
[3]	朱明娟,邢凯,亢泽峰,刘健. 甲状腺相关性眼病的诊断及治疗进展[J]. 山东大学耳鼻喉眼学报, 2018, 32(5): 110-113.
[4]	王坛,武珂,李连庆,宫丽丽. 皮下免疫治疗注射后出现全身不良反应的伴发因素及处理[J]. 山东大学耳鼻喉眼学报, 2018, 32(5): 71-74.
[5]	代亚错,李靖,万保罗,臧艳姿,黄颖铭. 个体化治疗咽喉部海绵状血管瘤二例[J]. 山东大学耳鼻喉眼学报, 2018, 32(4): 110-112.
[6]	刘义平,林远超. 负压引流防治腮腺术后涎瘘112例[J]. 山东大学耳鼻喉眼学报, 2018, 32(4): 65-67.
[7]	陈鸣,俞雪飞. 浅谈伴有变应性鼻炎的慢性鼻窦炎的治疗[J]. 山东大学耳鼻喉眼学报, 2018, 32(3): 18-22.
[8]	张桂敏,林鹏. 慢性鼻-鼻窦炎的内在型:从基础到临床[J]. 山东大学耳鼻喉眼学报, 2018, 32(3): 14-17.
[9]	覃纲,梁灼萍. 变应性真菌性鼻-鼻窦炎免疫治疗现状[J]. 山东大学耳鼻喉眼学报, 2018, 32(3): 23-26.
[10]	吴湘萍. 患者管理方式对变应性鼻炎舌下含服粉尘螨滴剂疗效的影响[J]. 山东大学耳鼻喉眼学报, 2018, 32(3): 68-72.
[11]	钟建文,刘大波,罗向前,黄振云,仇书要,程超,杨李强,易新华,曾锦鸿. 可穿戴设备在儿童阻塞性睡眠呼吸暂停诊断中的应用[J]. 山东大学耳鼻喉眼学报, 2018, 32(2): 30-33.
[12]	高进良,年婉清,李烁. 鼻内镜手术联合鼻用糖皮质激素治疗腺样体肥大性[J]. 山东大学耳鼻喉眼学报, 2018, 32(2): 38-42.
[13]	吕丹,李明霞,马兰枝,张馨元,肖浩,陈飞,刘均,李珍. 累及纵膈的头颈部丛状I型神经纤维瘤病两例[J]. 山东大学耳鼻喉眼学报, 2018, 32(1): 82-86.
[14]	李俏丽,李超,王薇,蔡永聪,孙荣昊,周雨秋,税春燕, 黄璐,涂静. 术后放化疗后复发并侵及侧颅底的原发性腮腺鳞状细胞癌一例[J]. 山东大学耳鼻喉眼学报, 2018, 32(1): 87-88.
[15]	陈红,曹慧玲,窦鑫,高下. 右侧鼻腔小细胞神经内分泌癌一例并文献复习[J]. 山东大学耳鼻喉眼学报, 2018, 32(1): 89-92.

多维度评价

Viewed

Full text

Abstract

Cited

Shared

Discussed